These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8382704)

  • 21. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
    Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
    Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
    J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biological distribution of 131I-HAb18F(ab')2 in patients with hepatocellular carcinoma].
    Lu W; Li X; Wang C; Liu W; Jiao H; Mo T; Chen Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Dec; 20(4):689-91. PubMed ID: 14716878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Application of radiolabeled anti-HBx monoclonal antibody for HCC targeting therapy].
    Li J; Tang Z; Liu K
    Zhonghua Yi Xue Za Zhi; 1996 Apr; 76(4):271-4. PubMed ID: 8758272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma.
    Hu PH; Pan LH; Wong PT; Chen WH; Yang YQ; Wang H; Xiang JJ; Xu M
    World J Gastroenterol; 2016 Jun; 22(21):5033-41. PubMed ID: 27275095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multimodality treatment and two-stage resection for unresectable hepatocellular carcinoma--experimental and clinical studies].
    Tang ZY
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):2-5. PubMed ID: 2163821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
    Pavlinkova G; Booth BJ; Batra SK; Colcher D
    Clin Cancer Res; 1999 Sep; 5(9):2613-9. PubMed ID: 10499640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.
    Behr TM; Sgouros G; Vougiokas V; Memtsoudis S; Gratz S; Schmidberger H; Blumenthal RD; Goldenberg DM; Becker W
    Int J Cancer; 1998 May; 76(5):738-48. PubMed ID: 9610734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoreduction and sequential resection for surgically verified unresectable hepatocellular carcinoma: evaluation with analysis of 72 patients.
    Tang ZY; Uy YQ; Zhou XD; Ma ZC; Lu JZ; Lin ZY; Liu KD; Ye SL; Yang BH; Wang HW
    World J Surg; 1995; 19(6):784-9. PubMed ID: 8553666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma.
    Tang ZY; Zhou XD; Ma ZC; Wu ZQ; Fan J; Qin LX; Yu Y
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):495-8. PubMed ID: 15567731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of hepatocellular carcinoma by means of radiopharmaceuticals.
    Lambert B; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):980-9. PubMed ID: 16032439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.
    Greiner JW; Ullmann CD; Nieroda C; Qi CF; Eggensperger D; Shimada S; Steinberg SM; Schlom J
    Cancer Res; 1993 Feb; 53(3):600-8. PubMed ID: 8425194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative biodistribution and radioimmunotherapy of monoclonal antibody RS7 and its F(ab')2 in nude mice bearing human tumor xenografts.
    Stein R; Blumenthal R; Sharkey RM; Goldenberg DM
    Cancer; 1994 Feb; 73(3 Suppl):816-23. PubMed ID: 8306265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radioimmunotherapy with 131 I-labeled humanized anti-HBsAg Fab and anti-nucleus antigen monoclonal antibody chTNT in nude mice bearing human hepatocellular carcinoma].
    DU YF; Luo RC; Li GP; Li AM; Ding XM; Yan X; Huang K
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):460-2. PubMed ID: 18359714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody.
    Andratschke M; Gildehaus FJ; Johannson V; Schmitt B; Mack B; Reisbach G; Lang S; Lindhofer H; Zeidler R; Wollenberg B; Luebbers CW
    Anticancer Res; 2007; 27(1A):431-6. PubMed ID: 17352264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of 131I-labelled anti-episialin 139H2 with cisplatin, cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenografts.
    Molthoff CF; Pinedo HM; Schlüper HM; Rutgers DH; Boven E
    Int J Cancer; 1992 Apr; 51(1):108-15. PubMed ID: 1563830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
    Leung WT; Lau WY; Ho S; Chan M; Leung N; Lin J; Ho KC; Metreweli C; Johnson PJ; Li AK
    J Nucl Med; 1994 Aug; 35(8):1313-8. PubMed ID: 7519259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody.
    Stein R; Govindan SV; Hayes M; Griffiths GL; Hansen HJ; Horak ID; Goldenberg DM
    Clin Cancer Res; 2005 Apr; 11(7):2727-34. PubMed ID: 15814655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor vascular homing endgolin-targeted radioimmunotherapy in hepatocellular carcinoma.
    Duan CL; Hou GH; Liu YP; Liang T; Song J; Han JK; Zhang C
    Tumour Biol; 2014 Dec; 35(12):12205-15. PubMed ID: 25164610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.